A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 13885 participants.

Also called NCT01732822

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 13,885 participants (enrolled count) (from the registry)
Sponsor
  • AstraZeneca Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01732822
  • EudraCT 2011-004616-36
Other papers using this trial's data
  • Acute Limb Ischemia in Peripheral Artery Disease Circulation, 2019-08-13 DOI, PubMed 31238713
  • Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID Trial Journal of the American College of Cardiology, 2018-10-02 DOI, PubMed 30261955
  • Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial Journal of the American College of Cardiology, 2018-12-25 DOI, PubMed 30573030 PubMed links an erratum for this paper. Erratum: PMID 31296300
  • Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial Vascular medicine (London, England), 2019-10 DOI, PubMed 31339474
  • Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial Journal of vascular surgery, 2022-02 DOI, PubMed 34597783
  • Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors: Insights from the EUCLID trial Vascular medicine (London, England), 2021-12 DOI, PubMed 34082620
  • Incidence and Factors Associated With Major Amputation in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial Circulation. Cardiovascular quality and outcomes, 2020-07 DOI, PubMed 32615798
  • Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial JAMA cardiology, 2019-01-01 DOI, PubMed 30540355, PMC6439683 Not in the PMC Open Access subset.
  • Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial American heart journal, 2020-02 DOI, PubMed 31783279
  • Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2018-01 DOI, PubMed 29273390
  • Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery Disease Journal of the American College of Cardiology, 2020-02-18 DOI, PubMed 32057375
  • Stroke in Patients With Peripheral Artery Disease Stroke, 2019-06 DOI, PubMed 31092165
  • Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease Circulation, 2017-01-17 DOI, PubMed 27840336
  • Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease The New England journal of medicine, 2017-01-05 DOI, PubMed 27959717
  • Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial Vascular medicine (London, England), 2018-12 DOI, PubMed 29992857
  • Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease Journal of the American Heart Association, 2022-06-07 DOI, PubMed 35621222, PMC9238734 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Brazil, Bulgaria, Canada, Chile, China, Czechia, France, Germany, Hungary, Italy, Japan, Mexico, Netherlands, Philippines, Poland, Romania, Russia, Slovakia, South Korea, Spain, Sweden, Thailand, Türkiye, Ukraine, United Kingdom, Vietnam (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01732822. Randomized; quadruple masking; primary purpose prevention. Start 2012-12-04 (actual); primary completion 2016-09-26 (actual). Results posted on 2017-10-30.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
Acronym
EUCLID
Condition
Peripheral Artery Disease
Intervention (Drug)
Ticagrelor
Intervention (Drug)
Clopidogrel
Lead sponsor
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct01732822
Content hash
a8be3f432d0a368fae7d6a349a9282b54cf58787e02d4f9e1b24234f859eecc7